Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -390,978 | -319,074 | -227,821 | -116,163 | -372,177 |
| Depreciation Amortization | 40,122 | 28,820 | 18,854 | 8,919 | 37,810 |
| Income taxes - deferred | -2,071 | -2,255 | 150 | -1,838 | -2,828 |
| Accounts receivable | -13,108 | 2,579 | 9,402 | -1,598 | -69,189 |
| Accounts payable and accrued liabilities | -6,661 | -1,448 | 2,945 | 2,052 | -7,841 |
| Other Working Capital | -24,266 | -16,973 | -8,440 | -17,630 | -127,021 |
| Other Operating Activity | 94,554 | 58,508 | 33,769 | 22,564 | 188,269 |
| Operating Cash Flow | $-302,408 | $-249,843 | $-171,141 | $-103,694 | $-352,977 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 81,332 | 71,237 | 43,381 | 22,078 | -32,769 |
| PPE Investments | -33,836 | -24,516 | -13,672 | -6,211 | -11,069 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -52,573 |
| Investing Cash Flow | $47,496 | $46,721 | $29,709 | $15,867 | $-96,411 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 307,832 | 251,215 | 162,693 | 148,959 | 403,522 |
| Other Financing Activity | -7,059 | -6,614 | -6,148 | -5,644 | -12,858 |
| Financing Cash Flow | $300,773 | $244,601 | $156,545 | $143,315 | $390,664 |
| Exchange Rate Effect | 1,144 | 567 | 1,247 | 508 | -541 |
| Beginning Cash Position | 122,053 | 122,053 | 122,053 | 122,053 | 181,318 |
| End Cash Position | 169,058 | 164,099 | 138,413 | 178,049 | 122,053 |
| Net Cash Flow | $47,005 | $42,046 | $16,360 | $55,996 | $-59,265 |
| Free Cash Flow | |||||
| Operating Cash Flow | -302,408 | -249,843 | -171,141 | -103,694 | -352,977 |
| Capital Expenditure | -33,836 | -24,516 | -13,672 | -6,211 | -11,069 |
| Free Cash Flow | -336,244 | -274,359 | -184,813 | -109,905 | -364,046 |